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General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1  Non-aqueous reagents were transferred under
nitrogen or argon via syringe or cannula.  Organic solutions were concentrated under
reduced pressure on a Büchi rotary evaporator.  Chromatographic purification of products
was accomplished using forced-flow chromatography on ICN 60 32-64 mesh silica gel 63
according to the method of Still.2  Thin-layer chromatography (TLC) was performed on
EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of the developed chromatogram
was performed by fluorescence quenching or KMnO4 stain.
1H and 13C NMR spectra were recorded on Bruker DRX-500 (500 MHz and 125 MHz,
respectively), Bruker AMX-400 (400 MHz and 100 MHz, respectively), Varian Mercury-
300 (300 MHz and 75 MHz, respectively), or Varian I-500 (500 MHz and 125 MHz,
respectively) instruments, as noted, and are internally referenced to residual protio solvent
signals.  Data for 1H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
                                                
1Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pregamon Press,
Oxford, 1988.
2Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
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(Hz), and assignment.  Data for 13C NMR are reported in terms of chemical shift. (δ ppm).
IR spectra were recorded on an ASI React-IR 1000 spectrometer and are reported in terms
of frequency of absorption (cm-1).  Mass spectra were obtained from the UC Irvine Mass
Spectral facility. Gas liquid chromatography (GLC) was performed on Hewlett-Packard
6850 and 6890 Series gas chromatographs equipped with a split-mode capillary injection
system and flame ionization detectors using a CC-1701 (30 m x 0.25 mm) column from
C&C Column Technologies.  High performance liquid chromatography (HPLC) was
performed on the Hewlett-Packard 1100 Series chromatographs using a 4.6 x 250 mm
Zorbax Sil column.
General Procedure A:  Preparation of the allylic diamines.  According to a modified
procedure of Werner,3 to a solution of the triphenylphosphonium halide salt in THF was
added t-BuOK portionwise.  After 1 h, a solution of the diaminoketone in THF was added
to the resulting orange mixture and heated to reflux.  After 12 h, the crude reaction mixture
was washed with 1 N HCl (50 mL).  The resulting aqueous layer was then separated and
washed with Et2O (3 x 50 mL) and then carefully adjusted to pH 12 with 1 N NaOH (50
mL).  The aqueous layer was then extracted with Et2O (3 x 50 mL) and the organic layers
combined, washed with brine (20 mL), dried (Na2SO4) and concentrated.  The resulting
residue was purified by chromatography on grade I alumina (Et2O) to furnish the title
compounds.
Morpholin-4-yl-acetic acid ethyl ester (16).  Morpholine (13.0 mL, 0.15 mol) was
added dropwise to a solution of ethyl bromoacetate (10.5 g, 63.8 mmol) in toluene (100
mL).  After 8 h, the resulting mixture was filtered through a plug of Celite with Et2O and
                                                
3Werner, D. S.; Stephenson, G. Liebigs Ann. 1996, 1705.
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concentrated to provide 16 (10.2 g, 58.9 mmol) in 92% yield as a yellow oil, which was
used without further purification.  IR (CH2Cl2) 1745, 1455, 1297, 1197, 1166, 1034 cm-1;
1H NMR (400 MHz, CDCl3) δ 5.75 (q, J = 9.5 Hz, 2H, CH2CH3), 3.75 (t, J = 6.2 Hz, 4H,
O(CH2)2), 3.19 (s, 2H, CH2CO), 2.57 (t, J = 6.2 Hz, 4H, N(CH2)2, 1.27 (dt, J = 8.9, 0.8 Hz,
3H, CH2CH3); 13C NMR (100 MHz, CDCl3) δ 169.9, 66.6, 60.5, 59.6, 53.2, 14.1; LRMS
(FAB) m/z 174 (MH)+; HRMS (FAB) exact mass calc’d for (C8H15NO3H)+ requires m/z
174.4113, found m/z  174.1135.
1,3-Di-morpholin-4-yl-propan-2-one (17).  Following a modified version of the
procedure described by McElvain,4 a round bottom flask charged with 16 (10.0 g, 58.0
mmol) and NaOEt (2.0g, 29.0 mmol) was heated to 100 °C under reduced pressure (40
torr) with removal of EtOH by short path distillation.  After the evolution of EtOH had
ceased (2 h), the resulting black solid residue was dissolved in a hot solution of NaOH (64
g, 1.6 mol) and EtOH (240 mL) in H2O (320 mL) and then heated to reflux.  After 1.5 h,
the resulting solution was cooled to 23 °C and the aqueous layer was removed, extracted
with Et2O (3 x 200 mL).  The combined organic layers were then washed with brine (200
mL), dried (Na2SO4) and concentrated to afford (11.7 g, 51.3 mmol) of 17 as a yellow solid
in 60% yield which was used without further purification: mp 62 °C; IR (CH2Cl2) 1455,
1366, 1293, 1116, 1004, 869 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.74 (t, J = 6.2 Hz, 8H,
2 x O(CH2)2), 3.26 (s, 4H, (CH2)2CO), 2.50 (t, J = 6.2 Hz, 8H, 2 x N(CH2)2); 13C NMR
(100 MHz) 205.4, 66.8, 66.2, 53.9; LRMS (FAB) m/z 229 (MH)+; HRMS (FAB) exact
mass calc’d for (C11H20N2O3H)+ requires m/z 229.1552, found m/z  229.1555.
                                                
4
 Thomas, W.B.; McElvain, S.M. J. Am. Chem. Soc. 1934, 56, 1806.
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1,3-Dimorpholin-4-yl-2-ethylidene-propane (1). Prepared according to general
procedure A from ethyltriphenylphosphonium bromide (11.3 g, 30.3 mmol), t-BuOK (3.4
g, 30.0 mmol) and ketone 17 (1.40 g, 6.00 mmol) in THF (30 mL) to provide 1 as a white
solid (0.83 g, 3.5 mmol) in 58% yield: mp 41 °C; IR (CH2Cl2) 1455, 1366, 1293, 1116,
1004, 869 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.60 (q, J = 6.9 Hz, 1H, CH=C), 3.67 (m,
8H, 2 x N(CH2)2), 2.94 (s, 2H, CH2C=CH), 2.88 (s, 2H, CH2C=CH), 2.37 (bs, 8H, 2 x
O(CH2)2), 1.66 (d, J = 6.9 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ 132.7, 126.3,
67.1, 67.1, 64.0, 55.7, 53.7, 53.6, 13.2; LRMS (FAB) m/z 240 (M)+; HRMS (FAB) exact
mass calc’d for (C13H24N2O2)+ requires m/z 240.1838, found m/z 240.1907.
2-Chloromethylene-1,3-dimorpholin-4-yl-propane (12). Prepared according to general
procedure A from chloromethyltriphenylphosphonium chloride (6.68 g, 22.1 mmol), t-
BuOK (2.46 g, 21.9 mmol) and ketone 17 (1.00 g, 4.38 mmol) in THF (30 mL) to provide
12 as a yellow oil (0.79 g, 3.0 mmol) in 68% yield; IR (CH2Cl2) 2866, 2819, 1452, 1352,
1298, 1120, 1004, 865 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.21 (s, 1H, CH=C), 3.69 (t, J
= 4.6 Hz, 8H, 2 x O(CH2)2), 3.25 (s, 2H, CH2C=C), 3.01 (s, 2H, CH2C=C), 2.18-2.45 (m,
8H, 2 x N(CH2)2; 13C NMR (100 MHz, CDCl3) δ 138.9, 118.2, 55.6, 53.6, 67.1, 61.1;
LRMS (CI) m/z 261 (M)+; HRMS (CI) exact mass calc’d for (C12H21ClN2O2H)+ requires
m/z 261.2369, found m/z 261.1370.
1,3-Dimorpholin-4-yl-2-phenylthiomethylene-propane (15). Prepared according to
general procedure A from phenylthiomethyltriphenylphosphonium chloride (3.92 g, 9.31
mmol), t-BuOK (1.04 g, 9.31 mmol) and ketone 17 (1.00 g, 4.38 mmol) in THF (20 mL) to
provide 15 as a yellow oil (0.10 g, 3.0 mmol) in 7% yield; IR (CH2Cl2) 2814, 2250, 1583,
1455, 1293, 1116, 1007, 865 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.22-7.32 (m, 4H, Ph),
7.15-7.19 (m, 1H, Ph), 6.35 (s, 1H, CH=C), 3.63-3.66 (m, 8H, 2 x O(CH2)2), 3.09 (s, 2H,
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CH2C=C), 2.87 (s, 2H, CH2C=C), 2.38-2.43 (m, 8H, 2 x N(CH2)2; 13C NMR (100 MHz,
CDCl3) δ 136.6, 134.9, 129.0, 128.9, 126.3, 124.9, 67.0, 63.3, 57.8, 53.6, 53.5; LRMS (CI)
m/z 335 (MH)+; HRMS (CI) exact mass calc’d for (C18H26N2O2SH)+ requires m/z
335.1793, found m/z 335.1784.
3-(-N-methyl-morpholinyl)-4-(-N-morpholinyl)-but-2-enenitrile (14). Prepared
according to general procedure A from cyanomethyltriphenylphosphonium chloride (3.30 g,
11.0 mmol) and ketone 17 (500 mg, 2.19 mmol) in THF (22 mL) to provide 14 as a yellow
oil (120 mg, 3.0 mmol) in 22% yield; IR (CH2Cl2) 2980, 2872, 2247, 1710, 1112, 1116, 730
cm-1; 1H NMR (400 MHz) δ 5.75 (s, 1H, CH=C), 3.69-3.72 (m, 8H, 2 x O(CH2)2), 3.25 (s,
2H, CH2C=C), 3.13 (s, 2H, CH2C=C), 2.45-2.46 (bs, 8H, 2 x N(CH2)2; 13C NMR (100
MHz) δ 160.6, 116.3, 98.3, 66.7, 66.6, 61.1, 59.8, 53.5, 53.4; LRMS (CI) m/z 252 (MH)+;
HRMS (CI) exact mass calc’d for (C13H21N3O2H)+ requires m/z 252.1712, found m/z
252.1712.
Benzoic acid-2-(-N-methyl-morpholinyl)-3-(-N-morpholinyl)-propenyl ester (13).
Based upon a modified procedure of Boeckman5, a solution of benzoic acid 2-methyl-
propenyl ester6 (64.3 g, 0.365 mol) and NBS (136.4 g, 0.766 mol) in CCl4 (730 mL) at
reflux was added benzoyl peroxide (1.06 g, 4.38 mmol).  After 2 h, the reaction mixture was
filtered through a plug of Celite and concentrated to yield the dibromide, which was used
without further purification.  A solution of the crude dibromide in CH2Cl2 (3.2 L) was
treated with i-Pr2EtN (127 mL, 0.729 mol), followed by dropwise addition of morpholine
(64 mL, 0.73 mol) at 4 °C.  The reaction was then allowed to warm to 23 °C.  After 1.3 h,
                                                
5
 Boeckman, R. K.; Ko S.S. J. Am. Chem. Soc. 1982, 104, 1033.
6
 Olofson R. A.; Dang, V. A. J. Org. Chem. 1990, 58, 1.
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the reaction mixture was washed with H2O (3 x 600 mL), dried (Na2SO4), filtered,
concentrated and purified on with grade I alumina (Et2O) to afford the product 13 as a
yellow solid (62.0 g, 9.24 mmol) in 50% yield; mp 80 °C; IR (CH2Cl2) 1729, 1455, 1293,
1274, 1251, 1116, 1004, 865 cm-1; 1H NMR (400 MHz) δ (d, J = 7.2 Hz, 2H, Ar), 7.63
(app t, J = 7.4 Hz, 1H, Ar), 7.50 (app t, J = 7.6 Hz, 2H, Ar), 7.42 (s, 1H, CH=C), 3.68-3.72
(m, 8H, 2 x O(CH2)2), 3.21 (s, 2H, CH2C=C), 3.02 (s, 2H, CH2C=C), 2.46-2.49 (m, 8H, 2 x
N(CH2)2); 13C NMR (100 MHz) δ 163.4, 135.3, 133.7, 129.9, 129.0, 128.6, 119.4, 67.1,
58.8, 54.0, 53.8, 53.6; LRMS (FAB) m/z 347 (MH)+; HRMS (FAB) exact mass calc’d for
(C19H26N2O4H)+ requires m/z 347.1971, found m/z 347.1971.
1,3-Dipiperidin-2-ethylidene-1-yl-propane (11).  According to Werner,3 to a solution
of the (ethyl)triphenylphosphonium bromide (5.00 g, 13.5 mmol) in Et2O (50 mL) was
added dropwise n-BuLi (5.50 mL of a 2.47 M solution in hexanes, 13.5 mmol).  After 1 h,
the resulting orange mixture was cooled to –78 °C and 1,3-dichloroacetone (1.70 g, 13.5
mmol) in Et2O (50 mL) was added dropwise at which time a color change from dark orange
to yellow was observed.  The reaction mixture was then allowed to warm to 23 °C over 15 h
and then Et2O (100 mL) was added.  The resulting mixture was then filtered through a pad
of Celite© with Et2O (200 mL).  The organic layer was then separated, dried (Na2SO4), and
then concentrated at 0 °C to provide 1-chloro-2-(chloromethyl)-2-butene (18) (0.70 g, 2.68
mmol) in 37% yield which was used without further purification.  To a refluxing mixture of
piperidine (0.70 mL, 6.71 mmol ) and NaHCO3 (300 mg, 5.36 mmol) in H2O (1.0 mL) was
added 18.  After 2.5 h, the resulting mixture was washed with 1 N HCl (20 mL).  The
aqueous layer was then separated and washed with Et2O (3 x 20 mL) and then carefully
adjusted to pH 12 with 1 N NaOH (20 mL).  The aqueous layer was then extracted with
Et2O (3 x 50 mL) and the organic layers combined, washed with brine (20 mL), dried
(Na2SO4), and then concentrated.  The resulting residue was purified by chromatography on
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grade I alumina (Et2O) to furnish 11 as a yellow oil (300 mg, 1.27 mmol) in 47% yield. IR
(film) 2935, 2757, 1444, 1298, 1151, 989 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.57 (q, J =
6.9 Hz, 1H, CH=C), 2.89 (s, 2H, CH2C=CH), 2.86 (s, 2H, CH2C=CH), 2.31 (bs, 8H, 2 x
N(CH2)2), 1.66 (d, J = 6.9 Hz, 3H, CH3), 1.28-1.58 (m, 3.67, 8H, (CH2CH2)2N), 1.39-1.42
(m, 2H, CH2CH2CH2N); 13C NMR (100 MHz, CDCl3) δ 64.6, 56.9, 55.1, 54.9, 26.5, 25.0,
24.9 13.7.
1,3-Dipyrrolin-1-yl-2-ethylidene-propane (10). To a solution of pyrrolidine (7.75 mL,
93.0 mmol ) in THF (40.0 mL) at 23 °C was added 1-chloro-2-(chloromethyl)-2-butene
(18) (2.85 g, 18.56 mmol).  After 5 h, the resulting mixture was extracted with 1 N HCl (aq)
(40 mL).  The resulting aqueous layer was washed with Et2O (3 x 40 mL) and then
carefeully adjusted to pH 12 with 1 N NaOH (40 mL).  The aqueous layer was then
extracted with Et2O (3 x 50 mL) and the organic layers combined, washed with brine (20
mL), dried (Na2SO4), and concentrated.  The resulting residue was purified by
chromatography on grade I basic alumina (Et2O) to furnish 10 as a colorless oil (600 mg,
2.88 mmol) in 16% yield.  IR (film) 2966, 2781, 1630, 1267, 1197 cm-1; 1H NMR (300
MHz) δ 5.58 (q, J = 6.9 Hz, 1H, CH=C), 3.09 (s, 2H, CH2C=CH), 3.07 (s, 2H,
CH2C=CH), 2.46-2.47 (m, 8H, 2 x N(CH2)2), 1.71-1.80 (m, 8H, (CH2CH2)2N), 1.71 (d, J =
4.2 Hz, 3H, CH3); 13C NMR (75 MHz) δ 64.6, 56.9, 55.1, 54.9, 26.5, 25.0, 24.9 13.7;
LRMS (FAB) m/z 209 (MH)+; HRMS (FAB) exact mass calc’d for (C13H24N2H)+ requires
m/z 209.2015, found m/z 209.2018.
General Procedure B:  To a flask charged with TiCl4•(THF)2 was added the allyl
dimorpholine in CH2Cl2, followed by i-Pr2NEt.  The resulting solution was then cooled to
–20 °C for 5 min before the acid chloride in CH2Cl2 was added dropwise over 1 min, unless
noted otherwise.  The resulting dark red solution was maintained at –20 °C until the allyl
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dimorpholine was consumed (4-6 h) as determined by TLC analysis (EtOAc).  The
resulting solution was then diluted with EtOAc (20 mL) and then washed with aqueous 1N
NaOH (20 mL).  The aqueous layer was then extracted with EtOAc (3 x 20 mL), and the
combined organic layers washed with brine, dried (Na2SO4), and concentrated.  The
resulting residue was purified by silica gel chromatography (EtOAc) to afford the title
compounds.
General Procedure C:  To a flask containing Yb(OTf)3 was added the allyl dimorpholine
in CH2Cl2, followed by i-Pr2NEt at 23 °C.  After 5 min a solution of the acid chloride in
CH2Cl2 was added dropwise over 1 min. The resulting dark red solution was maintained at
23 °C until the allyl dimorpholine was consumed (4-6 h) as determined by TLC analysis
(EtOAc).  The reaction mixture was then diluted with EtOAc (20mL) and washed with
aqueous 1N NaOH (20 mL).  The aqueous layer was then extracted with EtOAc (3 x 20
mL), and the combined organic layers washed with brine, dried (Na2SO4), and concentrated.
The resulting residue was purified by silica gel chromatography (EtOAc) to afford the title
compounds.
(2R*,3R*,6R*)-1,7-Dimorpholin-4-yl-4-methylene-2,3,6-trimethyl-heptane-1,7-
dione (9).  Prepared according to the general procedure C from 1 (50.0 mg, 0.208 mmol),
Yb(OTf)3  (258mg, 0.416 mmol), i-Pr2NEt (0.15 mL, 0.83 mmol), and propionyl chloride
(0.75 mL, 1 M solution in CH2Cl2, 0.75 mmol) in 4.0 mL of CH2Cl2 to provide the title
compound as a colorless oil in 97% yield (71.4 mg, 0.203 mmol); 98:2 syn–anti:anti–anti.
Syn–anti isomer: IR (CH2Cl2) 2976, 2864, 1733, 1637, 1463, 1436, 1374, 1247, 1116, 1046
cm-1; 1H NMR (400 MHz, CDCl3) δ 4.72 (s, 2H, CH2=C), 3.43-3.68 (m, 16H, 2 x
O(CH2CH2)2N), 2.90 (m, 1H), 2.72 (m, 1H), 2.49 (dd, J = 7.3, 14.6 Hz, 1H,
CH(H)C=CH2), 2.36 (m, 1H), 2.0 (dd, J = 6.4, 14.6, 1H, CH(H)C=CH2), 1.07 (d, J = 6.5
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Hz, 3H, CH3), 1.04 (d, J = 4.5 Hz, 3H, CH3), 1.00 (d, J = 6.3 Hz, 3H, CH3); 13C NMR (100
MHz) δ 174.7, 174.7, 152.2, 109.5, 67.0, 66.8, 46.1, 45.9, 42.1, 41.9, 40.6, 40.2, 40.0, 39.6,
33.4, 17.7, 17.3, 17.2, 15.3; LRMS (FAB) m/z 353 (MH)+; HRMS (FAB) exact mass
calc’d for (C19H32N2O4H)+ requires m/z 353.2440, found m/z 353.2444.  Diastereomer
ratio was determined by GLC with a CC-1701 column (100 °C, 20 °C/min gradient, 25 psi);
syn–anti adduct tr = 43.0 min, syn–syn adduct tr = 44.0 min, and anti–anti adduct tr = 51.8
min.
(2R*,3R*,6R*)-1,7-Dipiperidin-1-yl-4-methylene-2,3,6-trimethyl-heptane-1,7-
dione (Table 2, entry 3).  Prepared according to the general procedure C from 11 (50.0
mg, 0.212 mmol), Yb(OTf)3  (258mg, 0.416 mmol), i-Pr2NEt (0.15 mL, 0.85 mmol), and
propionyl chloride (0.80 mL, 1 M solution in CH2Cl2, 0.80 mmol) in 4.0 mL of CH2Cl2 to
provide the title compound as a colorless oil in 99% yield (73.4mg, 0.203 mmol); 96:4
syn–anti:anti–anti.  Syn–anti isomer: IR (film) 3059, 2989, 2943, 2866, 2309, 1622, 1444,
1267, 911, 703 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.71 (s, 1H, CH(H)=C), 4.69 (s, 1H,
CH(H)=C), 3.33-3.58 (m, 8H, 2 x N(CH2)2), 2.71-2.81 (m, 1H, CH(CO)), 2.47 (dd, J = 7.1,
14.6 Hz, 1H, CH(H)C=CH2), 2.32-2.51 (m, 1H), 1.98 (dd, J = 6.6, 14.7, 1H,
CH(H)C=CH2), 1.41-1.63 (m, 12 H, 2 x CH2CH2CH2), 1.04 (d, J = 6.9 Hz, 3H, CH3), 1.00
(d, J = 4.8 Hz, 3H, CH3), 0.98 (d, J = 5.1 Hz, 3H, CH3); 13C NMR (75 MHz) δ 174.5,
174.3, 152.4, 109.5, 43.2, 43.1, 41.0, 40.3, 39.9, 26.1, 27.1, 26.1, 26.0, 25.0, 18.1, 17.3, 15.3;
LRMS (FAB) m/z 350 (MH)+; HRMS (FAB) exact mass calc’d for (C21H36N2O2H)+
requires m/z 349.2855, found m/z  349.2854.  Diastereomer ratio was determined by GLC
with a CC-1701 column (100 °C, 20 °C/min gradient, 25 psi); syn–anti adduct tr = 30.1min,
syn–syn adduct tr = 31.1min, and anti–anti adduct tr = 36.6 min.
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(2R*,3R*,6R*)-1,7-Dipyrrolidin-1-yl-4-methylene-2,3,6-trimethyl-heptane-1,7-
dione (Table 2, entry 2).  Prepared according to the general procedure C from 10
(43.3mg, 0.208 mmol), Yb(OTf)3  (258mg, 0.416 mmol), i-Pr2NEt (0.30 mL, 1.72. mmol),
and propionyl chloride (1.04 mL, 1 M solution in CH2Cl2, 0.80 mmol) added by syringe
pump over 1 h in 4.0 mL of CH2Cl2 to provide the title compound as a colorless oil in 90%
yield (65.3mg, 0.203 mmol); 95:5 syn–anti:anti–anti.  Syn–anti isomer: IR (film) 3059,
2989, 2943, 2866, 2309, 1622, 1444, 1267, 911, 703 cm-1; 1H NMR (300 MHz, CDCl3) δ
4.71 (s, 1H, CH(H)=C), 4.69 (s, 1H, CH(H)=C), 3.33-3.58 (m, 8H, 2 x N(CH2)2) 2.71-2.81
(m, 1H, CH(CO)), 2.47 (dd, J = 7.1, 14.6 Hz, 1H, CH(H)C=CH2), 2.32-2.51 (m, 1H), 1.98
(dd, J = 6.6, 14.7, 1H, CH(H)C=CH2), 1.41-1.63 (m, 12 H, 2 x CH2CH2CH2), 1.04 (d, J =
6.9 Hz, 3H, CH3), 1.00 (d, J = 4.8 Hz, 3H, CH3), 0.98 (d, J = 5.1 Hz, 3H, CH3); 13C NMR
(75 MHz) δ 174.5, 174.3, 152.4, 109.5, 43.2, 43.1, 41.0, 40.3, 39.9, 26.1, 27.1, 26.1, 26.0,
25.0, 18.1, 17.3, 15.3; LRMS (FAB) m/z 350 (MH)+; HRMS (FAB) exact mass calc’d for
(C21H36N2O2H)+ requires m/z 349.2855, found m/z  349.2854.  Diastereomeric ratios were
determined by GLC with a CC-1701 column (100 °C, 20 °C/min gradient, 25 psi); syn–anti
adduct tr = 30.1min, syn–syn adduct tr = 31.1min, and anti–anti adduct tr = 36.6 min.
(2S*,3R*,6R*)-3-Chloro-2,6-dimethyl-1,7-dimorpholin-4-yl-4-methylene-heptane-
1,7-dione (Table 2, entry 4).  Prepared according to the general procedure C from 12
(57.0 mg, 0.219 mmol), Yb(OTf)3 (258 mg, 0.416 mmol), i-Pr2NEt (0.15 mL, 0.83 mmol),
and propionyl chloride (0.75 mL, 1 M solution in CH2Cl2, 0.75 mmol) in 4.0 mL of CH2Cl2
to provide the title compound as a yellow oil in 98% yield (80.1 mg, 0.215 mmol); 99:1
syn–anti:syn–syn by GLC analysis.  Syn–anti isomer: IR (CH2Cl2) 1640, 1463, 1436, 1235,
1116, 1031, 911 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.06 (s, 1H, CH(H)=C), 4.89 (s, 1H,
CH(H)=C), 4.58 (d, J = 10.0 Hz, 1H, CHCl), 3.46-3.68 (m, 16H, 2 x O(CH2CH2,)2N), 3.14
(m, 1H, CHCHCl), 2.98 (m, 1H, COCHCH2), 2.58 (dd, J = 8.4, 14.8 Hz, 1H,
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CH(H)C=CH2), 2.16 (dd, J = 5.2, 14.8, 1H, CH(H)C=CH2), 1.34 (d, J = 12.4 Hz, 3H,
CH3), 1.11 (d, J = 6.8 Hz, 3H, CH3); 13C NMR (100 MHz) δ 174.3, 172.0, 146.1, 114.5,
67.0, 66.9, 66.8, 66.6, 46.1, 46.0, 42.1, 42.0, 40.9, 37.0, 36.6, 33.8, 18.2, 16.9; LRMS (FAB)
m/z 373 (M)+; HRMS (FAB) exact mass calc’d for (C18H29ClN2O4)+ requires m/z
372.8868, found m/z 373.1901.
(2S*,3R*,6R*)-2,6-Dimethyl-1,7-dimorpholin-4-yl-4-methylene-3-phenylsulfanyl-
heptane-1,7-dione (Table 2, entry 7).  Prepared according to the general procedure B
from 15 (51.0 mg, 0.152 mmol), TiCl4•(THF)2  (102 mg, 0.305 mmol), i-Pr2NEt (0.11 mL,
0.61 mmol), and propionyl chloride (0.46 mL, 1 M solution in CH2Cl2, 0.46 mmol) in 1.5
mL of CH2Cl2 to provide the title compound as a yellow oil in 70% yield (47.8 mg, 0.107
mmol); 93:7 syn–anti:anti–anti by 1H NMR analysis.  Syn–anti isomer: IR (film) 3491,
2974, 2858, 1637, 1437, 1359, 1305, 1236, 1112, 1027, 896, 742 cm-1; 1H NMR (400 MHz,
CDCl3) δ 7.37-7.40 (m, 2H, Ar), 7.21-7.29 (m, 3H, Ar), 4.73 (s, 1H, CH(H)=C), 4.47 (s,
1H, CH(H)=C), 3.84 (d, J = 10.8 Hz, 1H, CHSPh), 3.39-3.68 (m, 16H, 2 x
O(CH2CH2,)2N), 3.14 (m, 1H, CHCHSPh), 2.98 (m, 1H, (CO)CHCH2), 2.58 (dd, J = 8.4,
14.8 Hz, 1H, CH(H)C=CH2), 2.16 (dd, J = 5.2, 14.8, 1H, CH(H)C=CH2), 1.34 (d, J = 12.4
Hz, 3H, CH3), 1.11 (d, J = 6.8 Hz, 3H, CH3); 13C NMR (100 MHz) δ 174.2, 173.2, 146.3,
134.7, 132.7, 128.7, 127.3, 112.2, 66.8, 66.6, 57.0, 45.9, 41.9, 38.7, 38.6, 33.6, 18.4, 17.2;
LRMS (FAB) m/z 447 (MH)+; HRMS (FAB) exact mass calc’d for (C24H34N2O4SH)+
requires m/z 447.2318, found m/z 447.2315.
(2R*,3R*,6R*)-3-Cyano-2,6-dimethyl-1,7-dimorpholin-4-yl-4-methylene-heptane-
1,7-dione (Table 2, entry 6).  Prepared according to the general procedure B from 14
(45.0 mg, 0.179 mmol), TiCl4•(THF)2  (120 mg, 0.359 mmol), i-Pr2NEt (0.13 mL, 0.72
mmol), and propionyl chloride (0.54 mL, 1 M solution in CH2Cl2, 0.54 mmol) in 1.8 mL of
J. Am. Chem. Soc. Supporting Information S 12
CH2Cl2 to provide the title compound in 78% yield (50.7 mg, 0.139 mmol) as a white solid;
mp 92-94 °C; 97:3 syn–anti:anti–anti by 1H NMR and 13C NMR analysis.  Syn–anti
isomer: IR (film) 2794, 2920, 2858, 1637, 1444, 1359, 1267, 1112, 1035, 911 cm-1; 1H
NMR (400 MHz, CDCl3) δ 5.11 (s, 1H, CH(H)=C), 4.95 (s, 1H, CH(H)=C), 3.75 (d, J =
9.2 Hz, 1H, CHCN), 3.47-3.67 (m, 16H, 2 x O(CH2CH2,)2N), 3.10 (m, 1H, (CHCHCN),
2.92 (m, 1H, (CO)CHCH2), 2.54 (dd, J = 8.6, 15.0 Hz, 1H, CH(H)C=CH2 ), 2.14 (dd, J =
5.6, 15.2 Hz, 1H, CH(H)C=CH2), 1.30 (d, J = 6.8 Hz, 3H, CH3), 1.10 (d, J = 6.8 Hz, 3H,
CH3); 13C NMR (100 MHz) δ 173.7, 171.0, 140.8, 116.1, 112.2, 66.8, 66.7, 66.6, 46.0,
45.9, 42.2, 42.0, 40.5, 37.8, 37.2, 33.6, 17.9, 16.4; LRMS (CI) m/z 363 (M)+; HRMS (CI)
exact mass calc’d for (C19H29N3O4)+ requires m/z 363.2158, found m/z 363.2162.
(2R*,3R*,6R*)-3-Benzoate-2,6-dimethyl-1,7-dimorpholin-4-yl-4-methylene-
heptane-1,7-dione (Table 2, entry 5).  Prepared according to the general procedure C
from 13 (72.1 mg, 0.208 mmol), Yb(OTf)3 (258 mg, 0.416 mmol), i-Pr2NEt (0.15 mL, 0.83
mmol), and propionyl chloride (0.75 mL, 1 M solution in CH2Cl2, 0.75 mmol) in 4.0 mL of
CH2Cl2 to provide the title compound as a yellow oil in 86% yield (81.7 mg, 0.178 mmol);
91:9 syn–anti:syn–syn.  Syn–anti isomer: IR (CH2Cl2) 2247, 1722, 1637, 1440, 1274, 1116,
1031, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J = 9.0 Hz, 2H, Ar), 7.58 (t, J = 9.3,
1H, Ar), 7.45 (t, J = 9.5 Hz, 2H, Ar), 5.69 (d, J = 9.5 Hz, 1H, CHOBz), 5.19 (s, 1H,
CH(H)=C), 4.98 (s, 1H, CH(H)=C), 3.47-3.70 (m, 16H, 2 x O(CH2CH2,)2N), 3.25 (dt, J =
8.5, 17.5 Hz, 1H, CHCHOBz), 3.02 (app dt, J = 8.5, 20.4 Hz, 1H, (CO)CHCH2), 2.55 (dd,
J = 9.0, 18.0 Hz, 1H, CH(H)C=CH2 ), 2.14 (dd, J = 8.5, 18.0 Hz, 1H, CH(H)C=CH2), 1.24
(d, J = 8.5 Hz, 3H, CH3), 1.07 (d, J = 8.5 Hz, 3H, CH3); 13C NMR (100 MHz) δ 174.6,
171.7, 165.3, 145.1, 133.0, 130.0, 129.5, 128.4, 114.2, 76.0, 66.8, 46.2, 45.9, 42.1, 38.8,
37.4, 33.9, 17.7, 13.8; LRMS (CI) m/z 459 (MH)+; HRMS (CI) exact mass calc’d for
(C25H34N2O6H)+ requires m/z 459.2495, found m/z 459.2481.  Diastereomer ratio was
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determined by HPLC with a Zorbax SIL column (75:25 hexane:EtOH, 1.0 mL/min);
syn–anti adduct tr = 14.5 min, anti–anti adduct tr = 16.8 min.
(2R*,3S*,6R*)-1,7-Dimorpholin-4-yl-2,6-diphthalamido-4-methylene-3-methyl-
heptane-1,7-dione (Table 3, entry 3).  Prepared according to the general procedure C
from 1 (106 mg, 0.441 mmol), Yb(OTf)3 (516 mg, 0.882 mmol), i-Pr2NEt (0.31 mL, 1.8
mmol), and phthalylglycyl chloride (1.5 mL, 1 M solution in CH2Cl2, 1.5 mmol) added over
2 h via syringe pump in 8.0 mL of CH2Cl2 to provide the title compound as a light yellow
solid in 98% yield (266 mg, 0.432 mmol); 95:5 syn–anti:anti–anti.  Syn–anti isomer: IR
(CH2Cl2) 2972, 2864, 2254, 1776, 1718, 1656, 1382, 1116, 923 cm-1; 1H NMR (400 MHz,
CDCl3) δ 7.86 (dd, J = 3.2, 5.6 Hz, 2H, Phth), 7.84 (dd, J = 3.0, 5.6 Hz, 2H, Phth), 7.72 (d,
J = 3.0 Hz, 2H, Phth), 7.70 (d, J = 3.2 Hz, 2H, Phth), 5.42 (dd, J = 4.2, 11.3 Hz, 1H,
CH2CHNPhth), 5.09 (s, 1H, CH(H)=C), 5.02 (s, 1H, CH(H)=C), 4.95 (d, J = 10.4 Hz, 1H,
CHCHNPhth), 3.40-3.90 (m, 16H, 2 x O(CH2CH2,)2N), 2.98 (dd, J = 3.7, 14.3 Hz, 1H,
CHCHNPhth), 0.89 (d, J = 7.0 Hz, 3H, CH3 );  13C NMR (100 MHz) δ; 173.9, 171.0,
140.8, 116.1, 112.2, 66.8, 66.7, 66.6, 46.0, 45.9, 42.2, 42.0, 40.5, 37.8, 37.2, 33.6, 17.9, 16.4;
LRMS (FAB) m/z 615 (MH)+; HRMS (FAB) exact mass calc’d for (C33H34N4O8)+
requires m/z 615.2455, found m/z 615.2453.  Diastereomer ratio was determined by HPLC
with a Zorbax SIL column (75:25 hexane:EtOH, 1.0 mL/min); syn–anti adduct tr = 18.7
min, anti–anti adduct tr = 21.0 min.  Recrystallization from toluene/hexane afforded crystals
suitable for single crystal X-ray diffraction (vide infra).
(2S*,3R*,6S*)-2,6-Dibenzyl-1,7-dimorpholin-4-yl-3-methyl-4-methylene-heptane-
1,7-dione (Table 3, entry 2).  Prepared according to the general procedure C from 1 (54.0
mg, 0.225 mmol), Yb(OTf)3  (258 mg, 0.416 mmol), i-Pr2NEt (0.15 mL, 0.86 mmol), and
hydrocinnamoyl chloride (0.73 mL, 1 M solution in CH2Cl2, 0.73 mmol) in 4.0 mL of
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CH2Cl2 to provide the title compound as a white solid in 99% yield (113 mg, 0.224 mmol);
mp 125-126 °C; 92:8 syn–anti:anti–anti.  Syn–anti isomer: IR (CH2Cl2) 2974, 1637, 1444,
1236, 1120, 1035, 888 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.15-7.32 (m, 10H, Ph), 4.75(s,
1H, CH(H)=C), 4.73 (s, 1H, CH(H)=C), 3.71-3.78 (m, 1H), 3.60-3.66 (m, 1H), 3.53-3.57
(m, 1H), 3.45-3.49 (m,1H), 3,36-3.40 (m,1H), 3.18-3.34 (m, 5H), 3.06-3.15 (m, 3H), 2.90-
3.06 (m,1H), 2.96 (m,1H), 2.75-2.91 (m, 5H), 2.62-2.70 (m, 1H), 2.54-2.61 (m, 2H), 2.46-
2.51 (m, 1H), 2.23 (dd, J = 5.5, 15.0 Hz, 1H), 1.23 (d, J = 7.0 Hz, 3H, CH3); 13C NMR
(100 MHz, CDCl3) δ 173.1, 172.7, 151.7, 139.6, 139.5, 129.1, 129.0, 128.4, 128.3, 126.5,
126.4, 109.7, 66.6, 66.4, 66.1, 65.9, 48.1, 45.9, 45.8, 41.9, 41.6, 41.5, 41.0, 39.6, 38.8, 37.2,
18.2; LRMS (FAB) m/z 505 (MH)+; HRMS (FAB) exact mass calc’d for (C31H40N2O4H)+
requires m/z 505.3066, found m/z 505.3069.  Diastereomer ratio was determined by HPLC
with a Zorbax SIL column (82:18 hexane/EtOH, 1.0 mL/min); syn–anti adduct tr = 9.8 min,
anti–anti adduct tr = 9.2 min.
(2R*,3S*,6R*)-3-Benzoate-1,7-dimorpholin-4-yl-2,6-dipivaloate-4-methylene-
heptane-1,7-dione (Table 3, entry 5).  Prepared according to the general procedure B
from 13 (74.0 mg, 0.214 mmol), TiCl4•(THF)2  (271 mg, 0.812 mmol), i-Pr2NEt (0.30 mL,
1.7 mmol), and α-pivaloxyacetylchloride (0.75 mL, 1 M solution in CH2Cl2, 0.75 mmol) in
4.2 mL of CH2Cl2 at 23 °C to provide the title compound as a colorless oil in 71% yield
(95.9 mg, 0.152 mmol); 92:8 syn–anti:anti–anti by 1H and 13C NMR analysis.  Syn–anti
isomer: IR (film) 3059, 2981, 2255, 1730, 1661, 1452, 1267, 1151, 911, 718 cm-1; 1H NMR
(400 MHz, CDCl3) δ 7.98 (d, J = 8.4, 2H, Ar), 7.57 (m, 1H, Ar), 7.44 (m, 2H, Ar), 5.77 (dd,
J = 8.0, 24.8 Hz, 2H), 5.56 (dd, J = 6.0, 8.0 Hz, 1H), 5.46 (s, 1H, CH(H)=C), 5.31 (s, 1H,
CH(H)=C), 3.53-3.82 (m, 16H, 2 x O(CH2CH2,)2N), 2.63-2.65 (m, 2H), 1.11 (s, 18H, 2 x
C(CH3)3); 13C NMR (125 MHz) δ 177.6, 177.5, 168.1, 165.0, 164.8, 140.2, 133.4, 129.6,
129.2, 128.4, 118.9, 73.2, 69.8, 67.6, 66.7, 66.6, 46.2, 45.9, 42.4, 38.7, 38.4, 36.2, 26.8;
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LRMS (FAB) m/z 631 (MH)+; HRMS (FAB) exact mass calc’d for (C33H46N2O10H)+
requires m/z 631.3231, found m/z 631.3237.
(2R*,3S*,6R*)-1,7-Dimorpholin-4-yl-2,6-dipivaloate-3-methyl-4-methylene-
heptane-1,7-dione (Table 3, entry 4).  Prepared according to the general procedure B
from 1 (59.4 mg, 0.247 mmol), TiCl4•(THF)2  (316 mg, 0.946 mmol), i-Pr2NEt (0.34 mL,
2.0 mmol), and α-pivaloxyacetylchloride (0.86 mL, 1 M solution in CH2Cl2, 0.86 mmol) in
4.9 mL of CH2Cl2 at 23 °C to provide the title compound after purification by silica gel
chromatography (85:15 EtOAc/Hexane) as a yellow oil in 97% yield (126 mg, 0.240
mmol); >97:3 syn–anti:anti–anti by 1H NMR and 13C NMR analysis.  Syn–anti isomer: IR
(film) 3059, 2981, 1730, 1653, 1444, 1267, 1159, 911, 718 cm-1; 1H NMR (400 MHz,
CDCl3) δ 5.35 (dd, J = 4.0, 9.6 Hz, 1H, CH2CHOPv), 5.07 (d, J = 8.0 Hz, 1H, CHCHOPv),
5.01 (s, 1H, CH(H)=C), 4.99 (s, 1H, CH(H)=C ), 3.39-3.61 (m, 16H, 2 x O(CH2CH2,)2N),
2.68 (app t, J = 7.4 Hz, 1H, CHCH3), 2.47 (dd, J = 9.8, 14.2 Hz, 1H, CH2=C CH(H)), 2.37
(dd, J = 3.8, 14.6 Hz, 1H, CH2=C CH(H)), 1.15 (s, 9H, C(CH3)3), 1.14 (s, 9H, C(CH3)3),
1.06 (d, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz) δ 177.9, 177.7, 167.7, 167.7, 144.8,
115.4, 72.2, 67.4, 66.7, 46.3, 45.9, 42.4, 38.9, 38.6, 38.5, 38.1, 27.0, 26.9, 16.3; LRMS
(FAB) m/z 525 (MH)+; HRMS (FAB) exact mass calc’d for (C27H44N2O8H)+ requires m/z
525.3176, found m/z 525.3175.
(2R*,3S*,6R*)-3-Chloro-1,7-dimorpholin-4-yl-2,6-dipivaloate-4-methylene-
heptane-1,7-dione (Table 3, entry 6).  Prepared according to the general procedure B
with 12 (77.0 mg, 0.295 mmol), TiCl4•(THF)2  (374 mg, 1.12 mmol), i-Pr2NEt (0.41 mL,
2.4 mmol), and α-pivaloxyacetylchloride (1.0 mL, 1 M solution in CH2Cl2, 1.0 mmol) in
6.0 mL of CH2Cl2 at 23 °C to provide the title compound as an orange oil in 84% yield (135
mg, 0.248 mmol); >95:5 syn–anti:anti–anti by 1H NMR and 13C NMR.  Syn–anti  isomer:
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IR (film) 2974, 2927, 2866, 1730, 1653, 1452, 1274, 1151, 1074, 1027 cm-1; 1H NMR (300
MHz) δ 5.62 (d, J = 9.2 Hz, 1H, CHCHCl), 5.49 (t, J = 7.0 Hz, 1H, (CO)CHCH2), 5.39 (s,
1H, CH(H)=C), 5.25 (s, 1H, CH(H)=C), 4.83 (d, J = 9.2 Hz, 1H, CHCl), 3.40-3.70 (m,
16H, 2 x O(CH2CH2)2N), 2.63 (d, J = 6.9 Hz, 2H, H2C=CCH2), 1.24 (s, 9H, C(CH3)3),
1.21 (s, 9H, C(CH3)3); 13C NMR (125 MHz) δ 177.8, 177.4, 167.5, 165.2, 139.9, 120.1,
70.7, 67.4, 66.7, 66.6, 61.2, 59.8, 46.0, 42.6, 42.5, 38.9, 38.6, 36.0, 35.8, 27.0, 20.9, 20.3;
LRMS (FAB) m/z 545 (MH)+; HRMS (FAB) exact mass calc’d for (C26H41ClN2O8H)+
requires m/z 545.2630, found m/z 545.2736.
General Procedure D: Regioselective hydrolysis of the α,β-disubstituted amide
carbonyl of the tandem adducts by iodolactonization–reductive ring opening.
Following the Metz protocol,7 to a solution of the 1,7-di-morpholin-1,7-dione in 1:1
DME/H2O at 23 °C was added I2 and the resulting solution maintained in the absence of
light for 3 h.  At this point the solution was diluted with EtOAc (30 mL), and the resulting
mixture was washed successively with Na2S2O3 (10 % aq., 20mL), and brine (20 mL), and
then dried (Na2SO4) and concentrated to provide the corresponding iodolactone which was
used without further purification.  The resulting residue was dissolved in AcOH, treated
with Zn dust and then heated at 65 °C for 2 h.  At this pont the reaction mixture was cooled
to 23 °C and 1 N HCl (20 mL) was added.  After extraction with EtOAc (3 x 30 mL), the
combined organic layers were dried (Na2SO4) and concentrated.  The resulting residue was
purified by chromatography on silica gel (99:1 EtOAc/AcOH) to furnish the title
compounds.
                                                
7
 Metz, P. Tetrahedron 1993, 49, 6367.
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(2R*,3R*,6R*)-4-Methylene-7-morpholin-4-yl-2,3,6-trimethyl-heptanoic acid (19).
Prepared according to the general procedure D from 9 (49.0 mg, 0.139 mmol), I2 (100 mg,
0.42 mmol), and 0.70 mL 1:1 DME/H2O followed by Zn (91 mg, 1.39 mmol) and AcOH
(0.30 mL) to yield 19 as a white solid (32.8 mg, 0.115 mmol) in 83% yield; 92:8
regioselectivity by GLC analysis.  Major isomer (α,β-disubstituted acid): IR (film) 2974,
2927, 1722, 1614, 1452, 1375, 1236, 1112, 1035, 904 cm-1; 1H NMR (400 MHz, CDCl3) δ
4.86 (s, 1H, CH(H)=C), 4.77 (s, 1H, CH(H)=C), 3.57-3.69 (m, 8H, 2 x O(CH2CH2)2N),
2.89-2.96 (m, 1H, CH(COOH)), 2.60-2.67 (m, 1H, CH(CON)), 2.41-2.53 (m, 2H), 2.05-
2.12 (dd, J = 7.3, 14.6 Hz, 1H, CH(H)C=CH2), 1.13 (d, J = 5.2 Hz, 3H, CH3), 1.09 (d, J =
5.6 Hz, 3H, CH3), 1.02 (d, J = 5.6 Hz, 3H, CH3); 13C NMR (125 MHz) δ 180.3, 149.5,
111.0, 66.9, 66.7, 46.1, 42.8, 42.3, 41.6, 37.8, 33.5, 29.6, 17.5, 15.0, 12.7; LRMS (CI) m/z
284 (MH)+; HRMS (CI) exact mass calc’d for (C15H25NO4H)+ requires m/z 284.1862,
found m/z  284.1868.
(2S*,3R*,6S*)-2,6-Dibenzyl-3-methyl-4-methylene-7-morpholin-4-yl-heptanoic
acid (20).  Prepared according to the general procedure D from (2S*,3R*,6S*)-2,6-
Dibenzyl-4-methylene-3-methyl-1,7-dimorpholin-4-yl-heptane-1,7-dione (Table 3, entry 2),
(47.1 mg, 0.108 mmol), I2 (88.0 mg, 0.373 mmol), and 0.70 mL 1:1 DME/H2O followed by
Zn (53.0 mg, 0.811 mmol) and AcOH (1.0 mL) to yield 20 as a white solid (35.8 mg, 0.095
mmol) in 82% yield: 92:8 regioselectivity by 1H NMR analysis.  Major isomer (α,β-
disubstituted acid): IR (film) 3028, 2943, 2866, 2248, 1730, 1599, 1452, 1112, 911, 726
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.06-7.23 (10 H, Ar), 4.87 (s, 1H, CH(H)=C), 4.76 (s,
1H, CH(H)=C), 3.42-3.57 (m, 2H), 3.18-3.28 (m, 2H), 3.03-3.13 (m, 2H), 2.46-2.86 (m,
10H), 2.23 (dd, J = 5.3, 15.5 Hz, 1H, CH2=C CH(H)), 1.07 (d, J = 7.2 Hz, 3H, CH3); 13C
NMR (125 MHz) δ 178.0., 174.1, 149.3, 139.9, 139.4, 129.5, 129.3, 129.0, 128.8, 128.5,
128.3, 127.2, 126.7, 126.2, 109.7, 66.8, 66.2, 51.9, 46.6, 42.4, 42.8, 40.0, 37.6, 34.0, 33.7,
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30.1, 16.7; LRMS (ES) m/z 458 (M+Na)+; HRMS (ES) exact mass calc’d for
(C27H33NO4+Na)+ requires m/z 458.2307, found m/z  458.2318.
(2S*,3R*,6R*)-3-Benzoate-2,6-dimethyl-4-methylene-7-morpholin-4-yl-heptanoic
acid (21).  Prepared according to the general procedure D from (2R*,3R*,6R*)-3-
Benzoate-2,3-dimethyl-4-methylene-1,7-di-morpholin-4-yl-heptane-1,7-dione (Table 2,
entry 5), (27.8 mg, 60.6 µL), I2 (60.0 mg, 0.254 mmol), and 1.2 mL 1:1 DME/H2O,
followed by Zn (40 mg, 0.61 mmol) and AcOH (1 mL) to yield 21 as a white solid (20.7
mg, 53.3 µmol) in 88% yield: 83:17 regioselectivity by 1H NMR analysis.  Major isomer
(α,β-disubstituted acid): IR (film) 2981, 2935, 2866, 1722, 1637, 1452, 1274, 1112, 1027,
966, 850 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 9.0 Hz, 2H, Ar), 7.58 (app t, J =
9.3, 1H, Ar), 7.45 (app t, J = 9.5 Hz, 2H, Ar), 5.69 (d, J = 5.0 Hz, 1H, CHOBz), 5.09 (s, 1H,
CH(H)=C), 4.98 (s, 1H, CH(H)=C), 3.49-3.76 (m, 8H, 2 x O(CH2CH2,)2N), 2.99-3.05 (m,
2H), 2.61 (dd, J = 7.0, 14.5 Hz, 1H, CH(H)C=CH2 ), 2.18 (dd, J = 6.5, 15.0 Hz, 1H,
CH(H)C=CH2), 1.28 (d, J = 7.0 Hz, 3H, CH3), 1.13 (d, J = 8.5 Hz, 3H, CH3); 13C NMR
(125 MHz) δ 176.8, 175.2, 165.3, 143.5, 133.2, 129.6, 128.5,128.4, 113.9, 75.6, 66.8, 66.7,
46.1, 42.4, 41.8, 36.9, 34.0, 17.8, 10.9; LRMS (CI) m/z 389.1 (M)+; HRMS (CI) exact
mass calc’d for (C21H27NO6)+ requires m/z 389.1838, found m/z 389.1845.  The solid was
recrystallized from toluene/hexanes to afford crystals suitable for single crystal X-ray
diffraction (vide infra).
























